Novel coronavirus disease-2019 (COVID-19) in people with rheumatic disease: Epidemiology and outcomes

Analysis of therapeutic targets for SARS-CoV-2 and discovery of potential drugs by computational methods

(2020) Canrong Wu et al.   Acta Pharmaceutica Sinica B

Clinical characteristics and outcomes of patients with coronavirus disease 2019 (COVID-19) and rheumatic disease: a comparative cohort study from a US ‘hot spot’

(2020) Kristin M D’Silva et al.   ANNALS OF THE RHEUMATIC DISEASES

Characteristics associated with hospitalisation for COVID-19 in people with rheumatic disease: data from the COVID-19 Global Rheumatology Alliance physician-reported registry

(2020) Milena Gianfrancesco et al.   ANNALS OF THE RHEUMATIC DISEASES

Corticosteroids, but not TNF Antagonists, are Associated with Adverse COVID-19 Outcomes in Patients With Inflammatory Bowel Diseases: Results from an International Registry

(2020) Erica J. Brenner et al.   GASTROENTEROLOGY

Trials of anti-tumour necrosis factor therapy for COVID-19 are urgently needed

(2020) Marc Feldmann et al.   LANCET

The COVID-19 Global Rheumatology Alliance: collecting data in a pandemic

(2020) Philip C. Robinson et al.   Nature Reviews Rheumatology

Hospitalization and Mortality among Black Patients and White Patients with Covid-19

(2020) Eboni G. Price-Haywood et al.   NEW ENGLAND JOURNAL OF MEDICINE

Covid-19 in Immune-Mediated Inflammatory Diseases — Case Series from New York

(2020) Rebecca Haberman et al.   NEW ENGLAND JOURNAL OF MEDICINE

Developing Covid-19 Vaccines at Pandemic Speed

(2020) Nicole Lurie et al.   NEW ENGLAND JOURNAL OF MEDICINE

The Rheumatology Community responds to the COVID-19 pandemic: the establishment of the COVID-19 global rheumatology alliance

(2020) Zachary S Wallace et al.   RHEUMATOLOGY

American College of Rheumatology Guidance for the Management of Adult Patients with Rheumatic Disease During the COVID‐19 Pandemic

(2020) Ted R. Mikuls et al.   Arthritis & Rheumatology

Serological tests confirm the low incidence of COVID-19 in chronic rheumatic inflammatory diseases treated with biological DMARD

(2020) Maurizio Benucci et al.   ANNALS OF THE RHEUMATIC DISEASES

EULAR provisional recommendations for the management of rheumatic and musculoskeletal diseases in the context of SARS-CoV-2

(2020) Robert BM Landewé et al.   ANNALS OF THE RHEUMATIC DISEASES

Epidemiology and outcomes of novel coronavirus 2019 in patients with immune-mediated inflammatory diseases

(2020) Milena Gianfrancesco et al.   CURRENT OPINION IN RHEUMATOLOGY

Persistent Symptoms in Patients After Acute COVID-19

(2020) Angelo Carfì et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Systemic or biologic treatment in psoriasis patients does not increase the risk of a severe form of COVID‐19

(2020) A.‐C. Fougerousse et al.   JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY

Factors associated with COVID-19-related death using OpenSAFELY

(2020) Elizabeth J. Williamson et al.   NATURE

The COVID-19 Global Rheumatology Alliance: evaluating the rapid design and implementation of an international registry against best practice

(2020) Jean W Liew et al.   RHEUMATOLOGY

Incidence of COVID-19 in a cohort of adult and paediatric patients with rheumatic diseases treated with targeted biologic and synthetic disease-modifying anti-rheumatic drugs

(2020) Xabier Michelena et al.   SEMINARS IN ARTHRITIS AND RHEUMATISM

Clinical Characteristics and Outcomes in Patients With Coronavirus Disease 2019 and Multiple Sclerosis

(2020) Céline Louapre et al.   JAMA Neurology

COVID‐19 in Patients with Inflammatory Arthritis: A Prospective Study on the Effects of Comorbidities and DMARDs on Clinical Outcomes

(2020) Rebecca H. Haberman et al.   Arthritis & Rheumatology

COVID‐19 in Rheumatic Diseases: A Research Agenda

(2020) Jinoos Yazdany   Arthritis & Rheumatology

Incidence of COVID‐19 in patients with rheumatic diseases treated with targeted immunosuppressive drugs: what can we learn from observational data?

(2020) Ennio Giulio Favalli et al.   Arthritis & Rheumatology

COVID-19 outcomes in MS

(2020) Erica Parrotta et al.   Neurology-Neuroimmunology & Neuroinflammation

Attitudes and Behaviors of Patients With Rheumatic Diseases During the Early Stages of the COVID-19 Outbreak

(2020) Margaret H.Y. Ma et al.   JOURNAL OF RHEUMATOLOGY

SARS-CoV-2 vaccines in development

(2020) Florian Krammer   NATURE

Potential COVID-19 papain-like protease PLpro inhibitors: repurposing FDA-approved drugs

(2020) Valentina L. Kouznetsova et al.   PeerJ

IBD in the COVID-19 era: the value of international collaboration

(2020) Erica J Brenner et al.   Lancet Gastroenterology & Hepatology

DMARDS and infections in rheumatoid arthritis

(2008) Roberto Caporali et al.   AUTOIMMUNITY REVIEWS